Evidence map›Paper›PMID 32052895›Full record

ArticleJournal of veterinary internal medicine2020

Effects of oral administration of 5 immunosuppressive agents on activated T-cell cytokine expression in healthy dogs.

Todd M Archer, Charlee Mulligan, Lakshmi Narayanan, Caitlin Riggs, Claire Fellman, John M Thomason, Robert W Wills, Dawn M Boothe, Crisanta Cruz-Espindola, Roy Harmon and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Todd M ArcherDepartment of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.ORCID https://orcid.org/0000-0003-2395-0810
Charlee MulliganDepartment of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
Lakshmi NarayananDepartment of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
Caitlin RiggsDepartment of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
Claire FellmanDepartment of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
John M ThomasonDepartment of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.ORCID https://orcid.org/0000-0001-5678-8923
Robert W WillsDepartment of Population and Preventative Medicine, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
Dawn M BootheDepartment of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
Crisanta Cruz-EspindolaDepartment of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
Roy HarmonDepartment of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
Andrew J MackinDepartment of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
Mississippi State University · USAuburn University · USTufts University · US

Funding

Dr. Hugh G. Ward Endowment ChairMississippi State University College of Veterinary Medicine Internal Competitive Research Grant
6 · The paper itself

Abstract

backgroundDogs are often adminstered >1 immunosuppressive medication when treating immune-mediated diseases, and determining whether these different medications affect IL-2 expression would be useful when performing pharmacodynamic monitoring during cyclosporine therapy. HYPOTHESIS/

objectivesTo determine the effects of 5 medications (prednisone, cyclosporine, azathioprine, mycophenolate mofetil, and leflunomide) on activated T-cell expression of the cytokines IL-2 and interferon-gamma (IFN-γ). ANIMALS: Eight healthy dogs.

methodsRandomized, cross-over study comparing values before and after treatment, and comparing values after treatment among drugs. Dogs were administered each drug at standard oral doses for 1 week, with a washout of at least 21 days. Activated T-cell expression of IL-2 and IFN-γ mRNA was measured by quantitative reverse transcription polymerase chain reaction. Blood drug concentrations were measured for cyclosporine, mycophenolate, and leflunomide metabolites.

resultsLeast squares means (with 95% confidence interval) before treatment for IL-2 (2.91 [2.32-3.50] ΔCt) and IFN-γ (2.33 [1.66-3.00 ΔCt]) values were significantly lower (both P < .001) than values after treatment (10.75 [10.16-11.34] and 10.79 [10.11-11.46] ΔCt, respectively) with cyclosporine. Similarly, least squares means before treatment for IL-2 (1.55 [1.07-2.02] ΔCt) and IFN-γ (2.62 [2.32-2.92] ΔCt) values were significantly lower (both P < .001) than values after treatment (3.55 [3.06-4.00] and 5.22 [4.92-5.52] ΔCt, respectively) with prednisone. Comparing delta cycle threshold values after treatment among drugs, cyclosporine was significantly different than prednisone (IL-2 and IFN-γ both P < .001), with cyclosporine more suppressive than prednisone. CONCLUSIONS AND CLINICAL IMPORTANCE: Prednisone and cyclosporine both affected expression of IL-2 and IFN-γ, suggesting that both have the ability to influence results when utilizing pharmacodynamic monitoring of cyclosporine treatment.

Indexed as

Administration, OralAnimalsAzathioprineCross-Over StudiesCyclosporineDogsFemaleImmunosuppressive AgentsInterferon-gammaInterleukin-2LeflunomideMaleMycophenolic AcidPrednisoneRandom AllocationT-LymphocytesAzathioprineCyclosporineImmunosuppressive AgentsInterferon-gammaInterleukin-2LeflunomideMycophenolic AcidPrednisoneazathioprinecyclosporineinterferon gammainterleukin 2leflunomidemycophenolate mofetilprednisone [Correction added on March 16, 2020, after first online publication: See Appendix S1 for correction details.]

Identifiers

PMID32052895
PMCPMC7255661
OpenAlexW3006599612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.